世界中西医结合杂志
世界中西醫結閤雜誌
세계중서의결합잡지
WORLD JOURNAL OF TRADITIONAL CHINESE AND WESTERN MEDICINE
2015年
5期
647-650
,共4页
李明%黄传兵%贾建云%刘轶菲%武敏%徐友霞
李明%黃傳兵%賈建雲%劉軼菲%武敏%徐友霞
리명%황전병%가건운%류질비%무민%서우하
健脾泄浊法%痛风性关节炎%临床研究%中医药
健脾洩濁法%痛風性關節炎%臨床研究%中醫藥
건비설탁법%통풍성관절염%림상연구%중의약
Therapy for Strengthening the Spleen and Removing the Turbid%Gouty Arthritis%Clini-cal Research%Chinese Herbal Medicine
目的:观察健脾泄浊法治疗急性期痛风性关节炎的临床疗效。方法将104例急性期痛风性关节炎患者随机分为两组。对照组52例,西药常规处理,治疗组52例,在西药常规处理基础上加用健脾泄浊法组方方药加减口服治疗,疗程为14 d。观察症状改善情况、炎性指标、尿 pH 值、血尿酸( BUA)和临床安全性等指标变化情况。结果治疗组总有效率为92.31%,对照组为88.46%,两组疗效比较,差异有统计学性意义(P ﹤0.05);治疗后两组患者的关节肿痛指数、VAS 评分、红细胞沉降率(ESR)、白细胞(WBC)、超敏 C 反应蛋白(hs - CRP)、中性粒细胞百分比(N%)、pH值等炎症指标均明显下降(P ﹤0.05);两组疼痛时间比较差异有统计学意义(P ﹤0.01);与对照组比较,治疗组无胃肠道不良反应(P ﹤0.01)、肝肾损害等明显不良反应。结论健脾泄浊方治疗急性期痛风性关节炎能够有效改善临床症状、降低血尿酸、碱化尿液、缩短疗程,且临床安全性优于单纯西药治疗者。
目的:觀察健脾洩濁法治療急性期痛風性關節炎的臨床療效。方法將104例急性期痛風性關節炎患者隨機分為兩組。對照組52例,西藥常規處理,治療組52例,在西藥常規處理基礎上加用健脾洩濁法組方方藥加減口服治療,療程為14 d。觀察癥狀改善情況、炎性指標、尿 pH 值、血尿痠( BUA)和臨床安全性等指標變化情況。結果治療組總有效率為92.31%,對照組為88.46%,兩組療效比較,差異有統計學性意義(P ﹤0.05);治療後兩組患者的關節腫痛指數、VAS 評分、紅細胞沉降率(ESR)、白細胞(WBC)、超敏 C 反應蛋白(hs - CRP)、中性粒細胞百分比(N%)、pH值等炎癥指標均明顯下降(P ﹤0.05);兩組疼痛時間比較差異有統計學意義(P ﹤0.01);與對照組比較,治療組無胃腸道不良反應(P ﹤0.01)、肝腎損害等明顯不良反應。結論健脾洩濁方治療急性期痛風性關節炎能夠有效改善臨床癥狀、降低血尿痠、堿化尿液、縮短療程,且臨床安全性優于單純西藥治療者。
목적:관찰건비설탁법치료급성기통풍성관절염적림상료효。방법장104례급성기통풍성관절염환자수궤분위량조。대조조52례,서약상규처리,치료조52례,재서약상규처리기출상가용건비설탁법조방방약가감구복치료,료정위14 d。관찰증상개선정황、염성지표、뇨 pH 치、혈뇨산( BUA)화림상안전성등지표변화정황。결과치료조총유효솔위92.31%,대조조위88.46%,량조료효비교,차이유통계학성의의(P ﹤0.05);치료후량조환자적관절종통지수、VAS 평분、홍세포침강솔(ESR)、백세포(WBC)、초민 C 반응단백(hs - CRP)、중성립세포백분비(N%)、pH치등염증지표균명현하강(P ﹤0.05);량조동통시간비교차이유통계학의의(P ﹤0.01);여대조조비교,치료조무위장도불량반응(P ﹤0.01)、간신손해등명현불량반응。결론건비설탁방치료급성기통풍성관절염능구유효개선림상증상、강저혈뇨산、감화뇨액、축단료정,차림상안전성우우단순서약치료자。
Objective To observe the clinical efficacy on acute gouty arthritis treated with the ther-apy for strengthening the spleen and removing the turbid. Methods One hundred and four patients of acute gouty arthritis were randomized into two groups. In a control group(52 cases),the routine management with western medicine was used. In a treatment group(52 cases),on the basis of the routine management with western medicine,the modified formula for strengthening the spleen and removing the turbid was applied for oral administration. The duration of treatment was 14 days. The improvement in symptoms,inflammatory inde-xes,urine pH value,BUA and clinical safety were observed. Results The total effective rate was 92. 31% in the treatment group and was 88. 46% in the control group,indicating the significant difference in comparison (P ﹤ 0. 05). After treatment,the joint swelling and pain index,VAS score,ESR,WBC,hs - CRP,N% and pH value were all apparently reduced in the two groups(P ﹤ 0. 05). The difference in pain duration was not significant in comparison of the two groups(P ﹤ 0. 01). Compared with the control group,there was no gastro-intestinal adverse reaction in the treatment group(P ﹤ 0. 01)and no apparent adverse reaction of liver and Kidney damages. Conclusion The therapy for strengthening the spleen and removing the turbid effectively relieves the clinical symptoms of acute gouty arthritis,reduces blood uric acid and alKaline urine and shortens the treatment period. The clinical safety is better than that treated with simple western medicine.